West Pharmaceutical Services (WST) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $43.0 million.
- West Pharmaceutical Services' Accumulated Depreciation & Amortization rose 696.52% to $43.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.0 million, marking a year-over-year increase of 696.52%. This contributed to the annual value of $155.4 million for FY2024, which is 1318.28% up from last year.
- West Pharmaceutical Services' Accumulated Depreciation & Amortization amounted to $43.0 million in Q3 2025, which was up 696.52% from $41.4 million recorded in Q2 2025.
- In the past 5 years, West Pharmaceutical Services' Accumulated Depreciation & Amortization registered a high of $1.3 billion during Q3 2023, and its lowest value of $35.6 million during Q1 2024.
- For the 5-year period, West Pharmaceutical Services' Accumulated Depreciation & Amortization averaged around $604.3 million, with its median value being $155.4 million (2024).
- Per our database at Business Quant, West Pharmaceutical Services' Accumulated Depreciation & Amortization surged by 1384.74% in 2023 and then tumbled by 9718.29% in 2024.
- West Pharmaceutical Services' Accumulated Depreciation & Amortization (Quarter) stood at $122.3 million in 2021, then fell by 1.39% to $120.6 million in 2022, then increased by 13.85% to $137.3 million in 2023, then increased by 13.18% to $155.4 million in 2024, then tumbled by 72.33% to $43.0 million in 2025.
- Its last three reported values are $43.0 million in Q3 2025, $41.4 million for Q2 2025, and $40.0 million during Q1 2025.